Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-05-15

Clinical Trial Update: Lubiprostone as a Treatment for Constipation in Parkinson's Disease [NA]

View source ↗

Summary

A terminated clinical trial examined lubiprostone for constipation in people with Parkinson's disease; results were posted in May 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Amitiza (lubiprostone)

Snippet

Sponsor: University of Arkansas | Conditions: Constipation, Parkinson's Disease | NA | Status: TERMINATED | Results posted: 2012-05-15